These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 1822395)
1. [Functional interaction between estrogen receptor and proto-oncogene products c-Jun and c-Fos]. Doucas V; Yaniv M C R Seances Soc Biol Fil; 1991; 185(6):464-74. PubMed ID: 1822395 [TBL] [Abstract][Full Text] [Related]
2. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Suzukawa K; Colburn NH Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401 [TBL] [Abstract][Full Text] [Related]
3. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095 [TBL] [Abstract][Full Text] [Related]
4. Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression. Planas-Silva MD; Donaher JL; Weinberg RA Cancer Res; 1999 Oct; 59(19):4788-92. PubMed ID: 10519385 [TBL] [Abstract][Full Text] [Related]
5. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor. Kim S; Brown PH; Birrer MJ Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es). Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873 [TBL] [Abstract][Full Text] [Related]
8. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli. Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313 [TBL] [Abstract][Full Text] [Related]
9. Expression and characterization of mouse cFos protein using the baculovirus expression system: ability to form functional AP-1 complex with coexpressed cJun protein. Corvello CM; Metz R; Bravo R; Armelin MC Cell Mol Biol Res; 1995; 41(6):527-35. PubMed ID: 8777432 [TBL] [Abstract][Full Text] [Related]
10. Heparin inhibits transcriptional activation by Fos and Jun oncoproteins. Busch SJ; Jackson RL; Sassone-Corsi P Trans Assoc Am Physicians; 1990; 103():21-7. PubMed ID: 2132533 [No Abstract] [Full Text] [Related]
11. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1). Hass R; Brach M; Kharbanda S; Giese G; Traub P; Kufe D J Cell Physiol; 1991 Oct; 149(1):125-31. PubMed ID: 1939341 [TBL] [Abstract][Full Text] [Related]
12. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Deng T; Karin M Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547 [TBL] [Abstract][Full Text] [Related]
13. Activation and inhibition of the AP-1 complex in human breast cancer cells. Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534 [TBL] [Abstract][Full Text] [Related]
14. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells. Cao W; Li F; Steinberg RH; LaVail MM Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868 [TBL] [Abstract][Full Text] [Related]
15. Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells. Yukimasa N; Isobe K; Nagai H; Takuwa Y; Nakai T Neuropeptides; 1999 Dec; 33(6):475-82. PubMed ID: 10657527 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis. Tzukerman M; Zhang XK; Pfahl M Mol Endocrinol; 1991 Dec; 5(12):1983-92. PubMed ID: 1791843 [TBL] [Abstract][Full Text] [Related]
17. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Dosch J; Kaina B Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539 [TBL] [Abstract][Full Text] [Related]
18. Elevation of AP1 activity during F9 cell differentiation is due to increased c-jun transcription. Yang-Yen HF; Chiu R; Karin M New Biol; 1990 Apr; 2(4):351-61. PubMed ID: 1963081 [TBL] [Abstract][Full Text] [Related]
19. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter. Jalava A; Mai S Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020 [TBL] [Abstract][Full Text] [Related]
20. Role of c-Jun concentration in neuronal cell death. Rössler OG; Steinmüller L; Giehl KM; Thiel G J Neurosci Res; 2002 Dec; 70(5):655-64. PubMed ID: 12424733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]